BOSTON – The Centers for Medicare & Medicaid Services may have dropped its accreditation requirement for bariatric surgery centers, but that hasn’t stopped the flow of data calling into question...
LONDON – More than 90% of patients with chronic hepatitis C and compensated cirrhosis treated with a triple-acting, all-oral, direct-acting antiviral (DAA) regimen achieved sustained virologic...
LONDON – Simvastatin improves short-term survival after variceal bleeding in patients with cirrhosis, results of a phase III, randomized, double blind study have shown.
At 2 years’ follow-up in the...
BOSTON – The risks of readmission and emergency surgery are low for patients with acute diverticulitis initially managed nonoperatively, a population-based, competing risk analysis found.
At a...
LONDON – A single daily pill containing two novel antiviral agents produced sustained virologic response rates of more than 90% in as little as 8-12 weeks in three multicenter, open-label phase III...
LONDON – Obeticholic acid significantly reduced key liver enzyme and bilirubin levels in patients with primary biliary cirrhosis in a phase III trial.
Results of <link...
Clonidine was not better than placebo for fecal incontinence despite previous reports to the contrary.
The finding, reported in the May issue of Clinical Gastroenterology and Hepatology (<link...
LAS VEGAS – Among 100 hip fracture patients at Salem (Ore.) Hospital, those fed within 24 hours left the hospital sooner, and fewer of them died. Other patients went up to a week without being...
Experts have signaled a need for the development of validated patient-reported outcomes for inflammatory bowel disease based on Food and Drug Administration guidance, in the face of a move toward the...
